Dexetimide

Dexetimide
Systematic (IUPAC) name
3-(1-benzyl-4-piperidyl)-3-phenylpiperidine-2,6-dione
Clinical data
AHFS/Drugs.com International Drug Names
Identifiers
21888-98-2 
N04AA08
PubChem CID 30843
IUPHAR ligand 354
DrugBank DB08997 
ChemSpider 28615 Yes
UNII 43477QYX3D Yes
KEGG D03711 Yes
ChEMBL CHEMBL1908364 
Chemical data
Formula C23H26N2O2
362.465 g/mol
  (what is this?)  (verify)

Dexetimide is a piperidine anticholinergic. It is a muscarinic antagonist that has been used to treat neuroleptic-induced Parkinsonism. Dexetimide was discovered at Janssen Pharmaceutica in 1968.[1][2]

References

  1. Dom, R.; Van Lommel, R.; Baro, F. (1971). "A quantitative study of neuroleptic-induced extrapyramidal symptoms and their response to dexetimide, a potent and long-acting antiparkinsonian agent". Acta Psychiatrica Scandinavica 47 (4): 399–410. doi:10.1111/j.1600-0447.1971.tb03697.x. PMID 4947805.
  2. Huygens, H.; Vereecken, J. L.; Tanghe, A. (1973). "Dexetimide (R 16470) in the control of neuroleptic-induced extrapyramidal side-effects. Its prophylactic value and duration of action". Psychiatria, neurologia, neurochirurgia 76 (4): 251–259. PMID 4581374.